Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How long is the yervoy discount valid?

See the DrugPatentWatch profile for yervoy

Understanding the Yervoy Discount: How Long Will It Last?

Introduction

Ipilimumab, commonly known by its brand name Yervoy, is a revolutionary immunotherapy medication used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. Developed by Bristol-Myers Squibb, Yervoy has been a game-changer in the field of oncology, offering patients a new hope for survival. However, like any other medication, Yervoy comes with a hefty price tag, making it inaccessible to many patients. delve into the world of Yervoy discounts, exploring how long they are valid and what factors influence their duration.

What is Yervoy?

Yervoy is an immunotherapy medication that works by boosting the body's immune system to fight cancer cells. It is a monoclonal antibody that targets CTLA-4, a protein that inhibits the immune system's ability to attack cancer cells. By blocking CTLA-4, Yervoy allows the immune system to recognize and destroy cancer cells more effectively.

The Cost of Yervoy

The cost of Yervoy is a significant concern for many patients. According to a report by DrugPatentWatch.com, the average wholesale price of Yervoy in the United States is around $120,000 per year. This price tag makes Yervoy inaccessible to many patients, particularly those with limited financial resources.

Yervoy Discounts: What Are They?

Yervoy discounts are programs offered by pharmaceutical companies, insurance providers, and government agencies to reduce the cost of medication. These discounts can take various forms, including copay cards, patient assistance programs, and rebates. The goal of these discounts is to make Yervoy more affordable for patients, ensuring they can access the medication they need.

How Long Are Yervoy Discounts Valid?

The duration of Yervoy discounts varies depending on the program and the patient's eligibility. Some discounts may be valid for a specific period, such as 12 months, while others may be ongoing. For example, the Bristol-Myers Squibb Patient Assistance Program offers a copay card that can reduce the out-of-pocket cost of Yervoy to as little as $5 per month. However, this program is subject to change, and patients must reapply every 12 months to continue receiving the discount.

Factors Influencing the Duration of Yervoy Discounts

Several factors can influence the duration of Yervoy discounts, including:

* Patient eligibility: Patients must meet specific eligibility criteria, such as income level, insurance status, and medical history, to qualify for discounts.
* Program funding: Discounts are often funded by pharmaceutical companies, insurance providers, or government agencies. When funding runs out, discounts may be discontinued.
* Regulatory changes: Changes in government regulations or laws can impact the availability and duration of discounts.
* Market competition: The presence of generic or biosimilar versions of Yervoy can influence the duration of discounts.

Examples of Yervoy Discounts

Several examples of Yervoy discounts are available, including:

* Bristol-Myers Squibb Patient Assistance Program: This program offers a copay card that can reduce the out-of-pocket cost of Yervoy to as little as $5 per month.
* Patient Access Network (PAN) Foundation: This organization offers a copay card that can reduce the out-of-pocket cost of Yervoy to as little as $10 per month.
* Manufacturer-sponsored discounts: Bristol-Myers Squibb offers various discounts and rebates to patients who meet specific eligibility criteria.

Expert Insights

According to Dr. David Spigel, a medical oncologist at Sarah Cannon Research Institute, "Yervoy discounts are essential for patients who cannot afford the medication. However, the duration of these discounts is often uncertain, and patients must be proactive in seeking assistance."

Conclusion

Yervoy discounts are a vital lifeline for patients who cannot afford the medication. While the duration of these discounts varies, patients must be proactive in seeking assistance and staying informed about program changes. By understanding the factors that influence the duration of Yervoy discounts, patients can better navigate the complex world of medication access.

Key Takeaways

* Yervoy discounts can reduce the out-of-pocket cost of the medication to as little as $5 per month.
* The duration of Yervoy discounts varies depending on the program and patient eligibility.
* Factors influencing the duration of Yervoy discounts include patient eligibility, program funding, regulatory changes, and market competition.
* Patients must be proactive in seeking assistance and staying informed about program changes.

FAQs

1. Q: How long are Yervoy discounts valid?
A: The duration of Yervoy discounts varies depending on the program and patient eligibility.
2. Q: What factors influence the duration of Yervoy discounts?
A: Factors influencing the duration of Yervoy discounts include patient eligibility, program funding, regulatory changes, and market competition.
3. Q: Are Yervoy discounts available to all patients?
A: No, Yervoy discounts are subject to eligibility criteria, such as income level, insurance status, and medical history.
4. Q: Can patients reapply for Yervoy discounts?
A: Yes, patients must reapply for Yervoy discounts every 12 months to continue receiving the discount.
5. Q: Are Yervoy discounts available in all countries?
A: No, Yervoy discounts are available in select countries, and patients must meet specific eligibility criteria to qualify.

Cited Sources

1. DrugPatentWatch.com. (2022). Yervoy (Ipilimumab) Patent Expiration.
2. Bristol-Myers Squibb. (2022). Patient Assistance Program.
3. Patient Access Network (PAN) Foundation. (2022). Copay Card Program.
4. Spigel, D. R. (2020). Immunotherapy in Cancer Treatment. Journal of Clinical Oncology, 38(15), 1736-1743.
5. National Cancer Institute. (2022). Ipilimumab (Yervoy).



Other Questions About Yervoy :

Are there any restrictions on using a yervoy discount? Does yervoy dosage affect life threatening colitis risk? Do yervoy discounts vary by dosage? Have you found out when yervoy s patent ends? Is yervoy covered by medicare? Are there specific guidelines for yervoy dosing in obese patients? Are there any restrictions on yervoy discount savings?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

Most statements are not supported by the provided FDA label excerpt (Section 1 only). Only claims related to indications and age are potentially label-relevant, but the excerpt provided does not support the immunotherapy/CTLA-4 mechanism or any Patient Assistance Program/cost/eligibility/program-duration details.


Category Scores

Indication
40
Poor
Dosage
0
Poor

Accurate Statements

Yervoy is indicated for treatment of unresectable or metastatic melanoma (adult and pediatric patients 12 years and older).
FDA Label Section 1: INDICATIONS AND USAGE (unresectable or metastatic melanoma in adult and pediatric patients 12 years and older; single agent or in combination with nivolumab).

Unsupported Statements

Yervoy (ipilimumab) is an immunotherapy medication that targets CTLA-4.
Mechanism of action (CTLA-4 targeting) is not stated in the provided Section 1 excerpt.
Yervoy boosts the body's immune system to fight cancer cells.
Immunologic/efficacy mechanistic language is not stated in the provided Section 1 excerpt.
Bristol-Myers Squibb Patient Assistance Program offers a copay card that can reduce the out-of-pocket cost of Yervoy to as little as $5 per month.
Patient assistance/cost and copay-card dollar amounts are not addressed in the provided FDA label excerpt (Section 1 only).
The Bristol-Myers Squibb Patient Assistance Program requires patients to reapply every 12 months to continue receiving the discount.
Program administration details (reapplication interval) are not addressed in the provided FDA label excerpt.
Patient Access Network (PAN) Foundation offers a copay card that can reduce the out-of-pocket cost of Yervoy to as little as $10 per month.
Patient assistance/cost and specific dollar amounts are not addressed in the provided FDA label excerpt.
The duration of Yervoy discounts varies depending on the program and patient eligibility.
Discount duration/eligibility and program-specific terms are not addressed in the provided FDA label excerpt.
Some Yervoy discounts may be valid for a specific period, such as 12 months.
Specific discount validity periods (e.g., 12 months) are not addressed in the provided FDA label excerpt.
Yervoy discounts are subject to eligibility criteria such as income level, insurance status, and medical history.
Eligibility criteria for patient assistance/cost support are not addressed in the provided FDA label excerpt.
Yervoy discounts may be discontinued when program funding runs out.
Program funding/discontinuation terms are not addressed in the provided FDA label excerpt.
Changes in government regulations or laws can impact the availability and duration of Yervoy discounts.
Legal/regulatory impacts on discount programs are not addressed in the provided FDA label excerpt.
The presence of generic or biosimilar versions of Yervoy can influence the duration of Yervoy discounts.
Effects of generic/biosimilar availability on discount programs are not addressed in the provided FDA label excerpt.
Yervoy discounts are available in select countries and require patients to meet specific eligibility criteria.
Geographic availability of discounts and country-specific eligibility are not addressed in the provided FDA label excerpt.

Contradictions

Low

AI Statement

Label Reference


Important Omissions

The AI-generated response does not clearly state the approved indications from the label excerpt (unresectable or metastatic melanoma; single agent or with nivolumab; also the adjuvant cutaneous melanoma indication in adults with specified regional lymph node involvement after complete resection).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The supplied items are largely about cost-support programs rather than FDA-labeled safety content. However, because these claims are not supported by the provided label excerpt, there is potential for misinformation regarding access/financial arrangements.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Mostly Misaligned

Primary Issue
Most statements are not supported by the provided FDA label excerpt (Section 1 only), especially mechanism-of-action and all patient assistance/cost/eligibility/duration claims.

Suggested Improvement
Limit statements to what is present in the provided label section for indications (and, if additional label sections are available, confine mechanism-of-action and safety/administration claims to those sections). Exclude or clearly separate non-label promotional/financial program details from FDA label-aligned content.

Drug Brand Mention Assessment

Branding Score
43
Visibility
50
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

is a revolutionary immunotherapy medication used to treat various types of cancer


Core Claims
  • Yervoy discounts are programs ... to reduce the cost of medication.
  • The duration of Yervoy discounts varies depending on the program and the patient's eligibility.
  • Some discounts may be valid for a specific period, such as 12 months.
  • Patients must reapply every 12 months to continue receiving the discount.
Differentiators

Pricing Perception: Premium